AKRO logo

Akero Therapeutics, Inc. (AKRO) Cash from operations

annual CFO:

-$230.11M-$84.74M(-58.29%)
December 31, 2024

Summary

  • As of today (September 16, 2025), AKRO annual cash flow from operations is -$230.11 million, with the most recent change of -$84.74 million (-58.29%) on December 31, 2024.
  • During the last 3 years, AKRO annual CFO has fallen by -$150.43 million (-188.79%).
  • AKRO annual CFO is now -5151.19% below its all-time high of -$4.38 million, reached on December 31, 2017.

Performance

AKRO Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROcash flow metrics

quarterly CFO:

-$48.25M+$19.42M(+28.70%)
June 30, 2025

Summary

  • As of today (September 16, 2025), AKRO quarterly cash flow from operations is -$48.25 million, with the most recent change of +$19.42 million (+28.70%) on June 30, 2025.
  • Over the past year, AKRO quarterly CFO has increased by +$9.21 million (+16.03%).
  • AKRO quarterly CFO is now -19121.51% below its all-time high of -$251.00 thousand, reached on June 30, 2018.

Performance

AKRO quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROcash flow metrics

TTM CFO:

-$253.42M+$9.21M(+3.51%)
June 30, 2025

Summary

  • As of today (September 16, 2025), AKRO TTM cash flow from operations is -$253.42 million, with the most recent change of +$9.21 million (+3.51%) on June 30, 2025.
  • Over the past year, AKRO TTM CFO has dropped by -$62.48 million (-32.73%).
  • AKRO TTM CFO is now -74877.51% below its all-time high of -$338.00 thousand, reached on March 31, 2018.

Performance

AKRO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AKRO Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-58.3%+16.0%-32.7%
3 y3 years-188.8%-147.3%-202.8%
5 y5 years-545.9%-113.6%-331.3%

AKRO Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-188.8%at low-147.3%+31.5%-202.8%+3.5%
5 y5-year-545.9%at low-257.2%+31.5%-331.3%+3.5%
alltimeall time-5151.2%at low<-9999.0%+31.5%<-9999.0%+3.5%

AKRO Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$48.25M(-28.7%)
-$253.42M(-3.5%)
Mar 2025
-
-$67.66M(+0.9%)
-$262.63M(+14.1%)
Dec 2024
-$230.11M(+58.3%)
-$67.09M(-4.7%)
-$230.11M(+8.7%)
Sep 2024
-
-$70.42M(+22.6%)
-$211.64M(+10.8%)
Jun 2024
-
-$57.45M(+63.5%)
-$190.94M(+22.5%)
Mar 2024
-
-$35.14M(-27.7%)
-$155.88M(+7.2%)
Dec 2023
-$145.37M(+57.1%)
-$48.63M(-2.2%)
-$145.37M(+18.9%)
Sep 2023
-
-$49.72M(+122.1%)
-$122.25M(+25.8%)
Jun 2023
-
-$22.39M(-9.1%)
-$97.15M(+3.1%)
Mar 2023
-
-$24.63M(-3.4%)
-$94.27M(+1.9%)
Dec 2022
-$92.52M(+16.1%)
-$25.51M(+3.6%)
-$92.52M(-1.3%)
Sep 2022
-
-$24.62M(+26.2%)
-$93.70M(+12.0%)
Jun 2022
-
-$19.51M(-14.7%)
-$83.69M(-0.6%)
Mar 2022
-
-$22.88M(-14.3%)
-$84.21M(+5.7%)
Dec 2021
-$79.68M
-$26.70M(+82.8%)
-$79.68M(+4.3%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$14.61M(-27.1%)
-$76.38M(+1.5%)
Jun 2021
-
-$20.03M(+9.2%)
-$75.28M(-3.3%)
Mar 2021
-
-$18.35M(-21.6%)
-$77.83M(+9.9%)
Dec 2020
-$70.80M(+98.7%)
-$23.39M(+73.2%)
-$70.80M(+19.9%)
Sep 2020
-
-$13.51M(-40.2%)
-$59.06M(+0.5%)
Jun 2020
-
-$22.58M(+99.6%)
-$58.76M(+41.6%)
Mar 2020
-
-$11.32M(-2.9%)
-$41.50M(+16.5%)
Dec 2019
-$35.63M(+670.3%)
-$11.65M(-11.8%)
-$35.63M(+36.7%)
Sep 2019
-
-$13.21M(+148.3%)
-$26.05M(+76.0%)
Jun 2019
-
-$5.32M(-2.2%)
-$14.80M(+52.1%)
Mar 2019
-
-$5.44M(+162.4%)
-$9.73M(+110.4%)
Dec 2018
-$4.63M(+5.5%)
-$2.08M(+5.8%)
-$4.63M(+81.4%)
Sep 2018
-
-$1.96M(+681.3%)
-$2.55M(+332.9%)
Jun 2018
-
-$251.00K(-25.7%)
-$589.00K(+74.3%)
Mar 2018
-
-$338.00K
-$338.00K
Dec 2017
-$4.38M
-
-

FAQ

  • What is Akero Therapeutics, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. annual CFO year-on-year change?
  • What is Akero Therapeutics, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. quarterly CFO year-on-year change?
  • What is Akero Therapeutics, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. TTM CFO year-on-year change?

What is Akero Therapeutics, Inc. annual cash flow from operations?

The current annual CFO of AKRO is -$230.11M

What is the all time high annual CFO for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high annual cash flow from operations is -$4.38M

What is Akero Therapeutics, Inc. annual CFO year-on-year change?

Over the past year, AKRO annual cash flow from operations has changed by -$84.74M (-58.29%)

What is Akero Therapeutics, Inc. quarterly cash flow from operations?

The current quarterly CFO of AKRO is -$48.25M

What is the all time high quarterly CFO for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high quarterly cash flow from operations is -$251.00K

What is Akero Therapeutics, Inc. quarterly CFO year-on-year change?

Over the past year, AKRO quarterly cash flow from operations has changed by +$9.21M (+16.03%)

What is Akero Therapeutics, Inc. TTM cash flow from operations?

The current TTM CFO of AKRO is -$253.42M

What is the all time high TTM CFO for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high TTM cash flow from operations is -$338.00K

What is Akero Therapeutics, Inc. TTM CFO year-on-year change?

Over the past year, AKRO TTM cash flow from operations has changed by -$62.48M (-32.73%)
On this page